BRPI0702158A - composição e método para a elevação do nìvel de glicose sanguìnea - Google Patents
composição e método para a elevação do nìvel de glicose sanguìneaInfo
- Publication number
- BRPI0702158A BRPI0702158A BRPI0702158A BRPI0702158A BR PI0702158 A BRPI0702158 A BR PI0702158A BR PI0702158 A BRPI0702158 A BR PI0702158A BR PI0702158 A BRPI0702158 A BR PI0702158A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- acid
- pharmaceutically acceptable
- effective amount
- blood glucose
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 4
- 239000008103 glucose Substances 0.000 title abstract 4
- 239000008280 blood Substances 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000003028 elevating effect Effects 0.000 title 1
- -1 polyoxyethylene Polymers 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 abstract 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 abstract 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
- 240000008067 Cucumis sativus Species 0.000 abstract 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 abstract 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 239000005642 Oleic acid Substances 0.000 abstract 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 108010039918 Polylysine Proteins 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
- 229940119217 chamomile extract Drugs 0.000 abstract 1
- 235000020221 chamomile extract Nutrition 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229940009662 edetate Drugs 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 abstract 1
- 229960004275 glycolic acid Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 229960000448 lactic acid Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 229960004488 linolenic acid Drugs 0.000 abstract 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 229940074096 monoolein Drugs 0.000 abstract 1
- 210000002200 mouth mucosa Anatomy 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 229940060184 oil ingredients Drugs 0.000 abstract 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
- 229960002969 oleic acid Drugs 0.000 abstract 1
- 235000021313 oleic acid Nutrition 0.000 abstract 1
- 229920000656 polylysine Polymers 0.000 abstract 1
- 229960001860 salicylate Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002562821A CA2562821A1 (en) | 2006-10-06 | 2006-10-06 | Composition and method for raising blood glucose level |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0702158A true BRPI0702158A (pt) | 2008-05-27 |
Family
ID=39399279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0702158 BRPI0702158A (pt) | 2006-10-06 | 2007-02-28 | composição e método para a elevação do nìvel de glicose sanguìnea |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU2007200571A1 (ru) |
| BR (1) | BRPI0702158A (ru) |
| MX (1) | MX2007006203A (ru) |
| NZ (1) | NZ553058A (ru) |
| RU (1) | RU2389493C2 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10016370B2 (en) * | 2011-07-14 | 2018-07-10 | Able Cerebral, Llc | Composition, device and method for delayed and sustained release of brain energy molecules |
| RU2634271C1 (ru) * | 2016-05-16 | 2017-10-24 | Александр Ливиевич Ураков | Средство для повышения физической выносливости |
-
2007
- 2007-02-07 NZ NZ55305807A patent/NZ553058A/en not_active IP Right Cessation
- 2007-02-09 AU AU2007200571A patent/AU2007200571A1/en not_active Abandoned
- 2007-02-28 BR BRPI0702158 patent/BRPI0702158A/pt not_active IP Right Cessation
- 2007-05-07 RU RU2007117018/15A patent/RU2389493C2/ru not_active IP Right Cessation
- 2007-05-23 MX MX2007006203A patent/MX2007006203A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007117018A (ru) | 2008-11-20 |
| RU2389493C2 (ru) | 2010-05-20 |
| MX2007006203A (es) | 2009-02-16 |
| AU2007200571A1 (en) | 2008-04-24 |
| NZ553058A (en) | 2008-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR073123A1 (es) | Composicion farmaceutica que comprende un taxano sustancialmente amorfo para utilizarse en el tratamiento de la enfermedad neoplasica | |
| PE20210401A1 (es) | Composiciones farmaceuticas que comprenden meloxicam | |
| PE20121498A1 (es) | Composiciones oftalmicas no irritantes de povidona-yodo | |
| BR9908121A (pt) | Forma galênica de liberação imediata e de liberação prolongada administrável por via oral compreendendo um agente estimulador de absorção e utilização deste agente estimulador de absorção | |
| CO4960645A1 (es) | Composicion farmaceutica de drogas antiinflamatorias no- esteroides y analogos de gaba y metodos para prevenir y tratar dano gastrointestinal, enfermedad inflamatoria del intestino irritable y sindrome de privacion del alcohol | |
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| TWI670057B (zh) | 治療乾眼用滴眼劑 | |
| JP5650947B2 (ja) | イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物 | |
| ES2572157T3 (es) | Composiciones en forma de partículas para la administración de fármacos poco solubles | |
| EA201190127A1 (ru) | Фармацевтические составы нитазоксанида с контролируемым высвобождением | |
| NZ611268A (en) | Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| CL2011001225A1 (es) | Formulacion farmaceutica en solucion acuosa que comprende desde 1% hasta 5% (p/v) de una sal de diclofenaco, desde 3% hasta 30% (p/v) de al menos un polioxialquilen ester de hidroxido de acido graso y un co-solvente seleccionado de etanol, propanol, glicerol, propilenglicol entre otros. | |
| RU2010139163A (ru) | Композиции для пероральной доставки метформина через слизистые оболочки | |
| BRPI0702158A (pt) | composição e método para a elevação do nìvel de glicose sanguìnea | |
| NZ603872A (en) | Oral dosage forms of bendamustine | |
| EA201390181A1 (ru) | Несущий корпус для лекарственного средства и способ его изготовления | |
| AR066666A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante | |
| MA38162B1 (fr) | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate | |
| CA2648751A1 (en) | Use of aminapthone for the preparation of a medicament for treating arteriopathies | |
| AR057570A1 (es) | Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o | |
| UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones | |
| WO2004009117A1 (ja) | Ｅｐ２アゴニストを有効成分とする子宮収縮抑制剤 | |
| CA2696918C (fr) | Compose pour son utilisation dans le traitement des neuropathies peripheriques | |
| Chole et al. | Clinical improvement in oral submucous fibrosis with Spirulina, a newer drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE 6A. ANUIDADE(S). |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2216 DE 25/06/2013. |